Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Bill Details

State

South Dakota

Session

2026 Regular Session

Chamber

House

Official Source

LegiScan

2026-03-10 H Signed by the Governor on March 10, 2026 H.J. 547

2026-03-05 H Delivered to the Governor on March 05, 2026 H.J. 520

2026-03-04 S Signed by the President S.J. 470

2026-03-03 H Signed by the Speaker H.J. 492

2026-03-02 S Senate Do Pass, Passed, YEAS 21, NAYS 12. S.J. 429

2026-02-26 S Remove from Consent Calendar S.J. 412

2026-02-25 S Certified uncontested, placed on consent S.J. 21

2026-02-25 S Health and Human Services Do Pass, Passed, YEAS 6, NAYS 0. S.J. 21

2026-02-25 S Scheduled for hearing S.J. 1

2026-02-10 S First read in Senate and referred to Senate Health and Human Services S.J. 234

2026-02-09 H House of Representatives Do Pass, Passed, YEAS 58, NAYS 7. H.J. 265

2026-02-05 H Health and Human Services Do Pass, Passed, YEAS 13, NAYS 0. H.J. 13

2026-02-05 H Scheduled for hearing H.J. 1

2026-01-21 H First read in House and referred to House Health and Human Services H.J. 104

2026-02-05 Do Pass Yea: 13 Nay: 0

2026-02-09 Do Pass Yea: 58 Nay: 7

2026-02-25 Do Pass Yea: 6 Nay: 0

2026-03-02 Do Pass Yea: 21 Nay: 12

2026-01-21 H Health and Human Services

2026-02-10 S Health and Human Services

2026-01-20 Introduced

2026-03-03 Enrolled

Controlled Substances Public Health and Safety